Résumé
MyoD, an essential transcription factor involved in muscle cell terminal differentiation, is regulated by acetylation, as are a number of other transcription factors, but the histone acetyltransferase enzyme responsible for this acetylation is a matter of controversy. In particular, contradictory findings have been reported concerning the ability of CBP/p300 to acetylate MyoD in vitro. Here we provide an explanation for this discrepancy: although full-length p300 does indeed acetylate MyoD, a fragment of p300 corresponding to its histone acetyltransferase domain does not. In addition to clearly demonstrating that p300 acetylates MyoD in vitro, these results underscore the necessity of using full-length histone acetyltransferase enzymes to draw valid conclusions from acetylation experiments.
| langue originale | Anglais |
|---|---|
| Pages (de - à) | 44502-44503 |
| Nombre de pages | 2 |
| journal | Journal of Biological Chemistry |
| Volume | 276 |
| Numéro de publication | 48 |
| Les DOIs | |
| état | Publié - 30 nov. 2001 |
Empreinte digitale
Examiner les sujets de recherche de « Acetylation of MyoD by p300 Requires More Than Its Histone Acetyltransferase Domain ». Ensemble, ils forment une empreinte digitale unique.Contient cette citation
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver